Literature DB >> 2849318

Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor.

K R Wong1, M H Xie, L B Shi, F Y Liu, C L Huang, D G Gardner, M G Cogan.   

Abstract

Current evidence suggests guanosine 3',5'-cyclic monophosphate (cGMP) serves as the second messenger for atrial natriuretic factor (ANF) in the kidney in vivo. We examined whether extracellular cGMP accumulation quantitatively reflected the concentration of cGMP within renal cells and whether urinary excretion of cGMP correlated with the physiological action of ANF. cGMP egression was examined in renal epithelial LLC-PK1 cells. ANF augmented intracellular cGMP concentration and extracellular cGMP appearance. Extracellular cGMP was an excellent function of the time-integrated intracellular cGMP concentration. In clearance studies in awake rats, urinary cGMP was primarily of renal cellular origin and correlated with the natriuresis induced by ANF in a time-dependent and concentration-dependent fashion. Urinary cGMP excretion may be useful as a biological marker for the renal activity of ANF in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849318     DOI: 10.1152/ajprenal.1988.255.6.F1220

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Effects of atrial natriuretic peptide and vasopressin on chloride transport in long- and short-looped medullary thick ascending limbs.

Authors:  H Nonoguchi; K Tomita; F Marumo
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 2.  Underfill and overflow revisited: mechanisms of nephrotic edema.

Authors:  M H Humphreys; J P Valentin; C Qiu; W Z Ying; W P Muldowney; D G Gardner
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

3.  Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.

Authors:  Lodi C W Roksnoer; Richard van Veghel; René de Vries; Ingrid M Garrelds; Usha M Bhaggoe; Edith C H Friesema; Frank P J Leijten; Marko Poglitsch; Oliver Domenig; Marian C Clahsen-van Groningen; Ewout J Hoorn; A H Jan Danser; Wendy W Batenburg
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

4.  Role of SRC family kinase in extracellular renal cyclic guanosine 3',5'-monophosphate- and pressure-induced natriuresis.

Authors:  Nilberto R F Nascimento; Brandon A Kemp; Nancy L Howell; John J Gildea; Cláudia F Santos; Thurl E Harris; Robert M Carey
Journal:  Hypertension       Date:  2011-04-11       Impact factor: 10.190

5.  Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.

Authors:  N Yokota; B G Bruneau; M L Kuroski de Bold; A J de Bold
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Contraluminal p-aminohippurate transport in the proximal tubule of the rat kidney. VII. Specificity: cyclic nucleotides, eicosanoids.

Authors:  K J Ullrich; G Rumrich; F Papavassiliou; S Klöss; G Fritzsch
Journal:  Pflugers Arch       Date:  1991-05       Impact factor: 3.657

7.  Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.

Authors:  J P Valentin; C Qiu; W P Muldowney; W Z Ying; D G Gardner; M H Humphreys
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus.

Authors:  L A Sechi; J P Valentin; C A Griffin; E Lee; E Bartoli; M H Humphreys; M Schambelan
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs.

Authors:  M A Perrella; K B Margulies; C M Wei; L L Aarhus; D M Heublein; J C Burnett
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

10.  Decreased levels of cGMP in vitreous and subretinal fluid from eyes with retinal detachment.

Authors:  E C La Heij; H G T Blaauwgeers; J de Vente; M Markerink; A T A Liem; A G H Kessels; H Steinbusch; F Hendrikse
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.